Skip to main content
. 2012 Mar 19;7:183–199. doi: 10.2147/COPD.S29820

Figure 4.

Figure 4

Incremental cost-effectiveness scatter plot (A) and CEAC (B), LAMA + LABA/ICS + roflumilast versus LAMA + LABA/ICS, 1000 runs.

Abbreviations: GBP, British pound; QALY, quality-adjusted life year; LABA, long-acting beta agonist; LAMA, long-acting muscarinic antagonist; ICS, inhaled corticosteroids.